Business

Burcon Announces Fiscal 2026 Third Quarter Results

Strong Q3 Revenue Growth Driven by Expanding Commercial TractionVancouver, British Columbia--(Newsfile Corp. - February 11, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein innovation, reported results for the fiscal third quarter ended December 31, 2025."Fiscal Q3 marked an important milestone in Burcon's commercial growth," said Kip Underwood, Burcon's chief executive officer. "We ramped production,.

articleBurcon Nutrascience CorporationFebruary 11, 202611/company/burcon-nutrascience-corporation/news/burcon-announces-fiscal-2026-third-210700139
Burcon Announces Fiscal 2026 Third Quarter Results

About this update from Burcon Nutrascience Corporation

[{"type":"text","content":"Strong Q3 Revenue Growth Driven by Expanding Commercial Traction","length":64,"tagName":"p","attribs":{"class":"nfSubHeading"},"className":""},{"type":"text","content":"Vancouver, British Columbia--(Newsfile Corp. - February 11, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein innovation, reported results for the fiscal third quarter ended December 31, 2025.","length":306,"tagName":"p"},{"type":"text","content":""Fiscal Q3 marked an important milestone in Burcon's commercial growth," said Kip Underwood, Burcon's chief executive officer. "We ramped production, fulfilled recurring customer orders, and strengthened key customer relationships, building momentum toward broader market adoption. With strong support from our manufacturing partner and insiders, we remain focused on scaling efficiently and executing our long-term growth strategy."","length":461,"tagName":"p"},{"type":"text","content":"Key Operational highlights for the third quarter ended December 31, 20251:","length":74,"tagName":"p"},{"type":"text","content":"Strong revenue growth: Revenue for the quarter was $739,000 up approximately 1100% from $61,000 in the prior-year period, driven by increased commercial production and repeat customer orders.","length":191,"tagName":"p","attribs":{}},{"type":"text","content":"Accelerating commercial momentum: Customer demand continued to exceed expectations resulting in the Company making targeted investments to accelerate growth and expand production capacity.","length":188,"tagName":"p","attribs":{}},{"type":"text","content":"Strengthening balance sheet: Closed a $1.25 million first tranche of a $6.9 million private placement of convertible debentures financing (the "Private Placement") through a direct investment from the Company's manufacturing partner owners, underscoring strong alignment and confidence in Burcon's long-term strategy.","length":335,"tagName":"p","attribs":{}},{"type":"text","content":"Management Commentary","length":21,"tagName":"p"},{"type":"text","content":"Fiscal 2026 third quarter was highlighted by strong revenue growth and expanding commercial momentum. Customer demand for Burcon's high-performance plant-based protein ingredients continue to ...

More updates from Burcon Nutrascience Corporation

Burcon NutraScience CorporationThe Companyprivate placementBurconcommercial productioncommercial orderscommercial growth